| Title |
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer
|
|---|---|
| Published in |
Investigational New Drugs, September 2019
|
| DOI | 10.1007/s10637-019-00814-3 |
| Pubmed ID | |
| Authors |
Rachel Goodwin, Derek Jonker, Eric Chen, Hagen Kennecke, Michael Cabanero, Ming-Sound Tsao, Michael Vickers, Caryn Bohemier, Howard Lim, Heather Ritter, Dongsheng Tu, Lesley Seymour |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 25% |
| Student > Bachelor | 6 | 21% |
| Other | 3 | 11% |
| Student > Doctoral Student | 2 | 7% |
| Librarian | 2 | 7% |
| Other | 4 | 14% |
| Unknown | 4 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 43% |
| Biochemistry, Genetics and Molecular Biology | 6 | 21% |
| Nursing and Health Professions | 3 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
| Computer Science | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 4 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2019.
All research outputs
#20,580,438
of 23,163,378 outputs
Outputs from Investigational New Drugs
#986
of 1,179 outputs
Outputs of similar age
#289,875
of 340,817 outputs
Outputs of similar age from Investigational New Drugs
#12
of 13 outputs
Altmetric has tracked 23,163,378 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,179 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,817 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.